Back to Rankings

CYRX

CryoPortD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
Current thesis
The post-earnings company release was materially better than the pre-print monitoring setup: revenue growth accelerated, commercial CGT and services trends stayed strong, adjusted EBITDA improved year over year, and management raised FY26 revenue guidance to $192 million-$196 million from $190 million-$194 million. That supports a modestly stronger positive bias than the April 28, 2026 baseline.
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -16.1.
What can break
Cryoport remains loss-making despite EBITDA improvement, so any growth slowdown could delay the pathway to profitability.
Momentum
79
Value
41
Sentiment
20
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.00 · Bull $14.00 · Bear $8.50
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-04 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $16.17
Why
Momentum79 · Δ7d -16.1
Value41 · Δ7d +0.1
Sentiment20 · Δ7d -1.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
79
26% active weight
Current posture
7d trendSoftening
Δ7d
-16.1
Δ21d
-15.2
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.0
Sentiment
20
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.4
Δ21d
-0.4
Why this grade

Composite grade D. Momentum 79.4 / Value 41.1 / Sentiment 19.6

Fundamentals (TTM)
As of 2026-07-20
Market Cap
$791.82M
Beta
1.66
Shares Out
50.4M
P/E (TTM)
8.3
P/S (TTM)
2.59
P/FCF (TTM) · Derived
-33.11
Rev YoY
+16.5%
EPS YoY
-18.1%
Gross Margin
+40.3%
Op Margin
-21.4%
Net Debt
-$180.49M
Current Ratio
2.09
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology